Drugs / DZIF-10c
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04631705 | Dec 2020 → Sep 2021 | COVID-19 | University of Cologne | Terminated | No outcome recorded |
| Phase 1/2 | NCT04631666 | Dec 2020 → Aug 2021 | COVID-19 | University of Cologne | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DZIF-10c | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04631705 ↗ |
| Modality | Monoclonal antibody | “SARS-CoV-2-neutralizing monoclonal antibody DZIF-10c” NCT04631666 ↗ |
| Route | Intravenous | “single intravenous infusion of DZIF-10c” NCT04631666 ↗ |